Successful Development of an Artificial Intelligence Model Using Deep Learning Approach to Establish Histological Sub-classification of Lung Cancer in Biopsy Specimens Whole Slide Images - Published in Scientific Reports -
Medmain Co., Ltd. (Headquarters: Fukuoka Prefecture, Fukuoka City, CEO: Osamu Iizuka, hereinafter referred to “Medmain”), a provider of “PidPort” pathological diagnosis support solutions, has succeeded in developing an artificial intelligence model to classify lung cancer subtypes in lung biopsy specimens using Deep Learning, which enables the sub-classification of the macarcinoma). A dissertation